Department of Health - Abu Dhabi, M42 and AbbVie Enter Strategic Partnership for Personalized Medicine and Genomics

The Department of Health – Abu Dhabi (DoH) has signed a Memorandum of Understanding with AbbVie Biopharmaceutical and M42 to advance personalised medicine and genomics in Abu Dhabi. The three parties aim to advance precision medicine in the diagnosis and treatment of multiple myeloma and non-small cell lung cancer. This strategic cooperation aims to maximise on the Emirate's unique genomics prog..